| Year |
Citation |
Score |
| 2020 |
Guo Z, Lei J, Wu S, Molina-Vega J, Cervantes P, Rom'Mand AR, Mijangos DCC, Falck JR, Lange C, Wang J, Potter DA. Abstract 4372: Metformin inhibits nuclear localization of estrogen receptor alpha in breast cancer cells, in part, by inhibition of CYP-mediated epoxyeicosatrienoic acid (EET) biosynthesis Epidemiology. 80: 4372-4372. DOI: 10.1158/1538-7445.Am2020-4372 |
0.405 |
|
| 2019 |
Guo Z, Wu S, Molina-Vega J, Castillo R, Barrera J, Johnson V, Lange C, Potter D. Abstract LB-023: CYP monooxygenases regulate nuclear localization of ERá and mTORC1 component RagC in ER+HER2- breast cancer cells Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-023 |
0.414 |
|
| 2018 |
Guo Z, Johnson V, Barrera J, Porras M, Hinojosa D, Hernández I, McGarrah P, Potter DA. Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them. Cancer Metastasis Reviews. PMID 30066055 DOI: 10.1007/S10555-018-9749-6 |
0.361 |
|
| 2017 |
Guo Z, Sevrioukova IF, Denisov IG, Zhang X, Chiu TL, Thomas DG, Hanse EA, Cuellar RAD, Grinkova YV, Langenfeld VW, Swedien DS, Stamschror JD, Alvarez J, Luna F, Galván A, et al. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chemical Biology. PMID 28919040 DOI: 10.1016/J.Chembiol.2017.08.009 |
0.405 |
|
| 2016 |
Guo Z, Sevrioukova I, Hanse E, Zhang X, Denisov I, Chiu T, Cuellar R, Torres C, Wulfkuhle J, Petricoin E, Cao Q, Chu H, Norris B, Schumacher R, Kelekar A, et al. Abstract 44: Hexyl-benzyl-biguanide (HBB) potently and selectively inhibits CYP3A4 epoxygenase activity and inhibits EET stabilization of mitochondrial respiration in ER+HER2- breast cancer cells, inducing glycolysis and pyruvate biosynthesis Cancer Research. 76: 44-44. DOI: 10.1158/1538-7445.Am2016-44 |
0.382 |
|
| 2015 |
Grossmann ME, Yang DQ, Guo Z, Potter DA, Cleary MP. Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis. Current Pharmacology Reports. 1: 312-323. PMID 26405648 DOI: 10.1007/S40495-015-0032-Z |
0.349 |
|
| 2015 |
Guo Z, Chu H, Berger AC, Tuttle TM, Zera R, Guttormson N, Nowak D, Bowers BJ, Kerr E, Boulanger K, Mordenti M, Miller JS, Yee D, Potter D. Effects of lumpectomy or mastectomy on plasma epoxyeicosatrienoic acid levels in patients with estrogen receptor positive, HER2-negative breast cancer. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E11563 |
0.322 |
|
| 2014 |
Guo Z, Chavez KJ, Alvarez J, Zhang X, Norris B, Maher M, Morgan M, Schumacher RJ, Cuellar R, Sevrioukova IF, Poulos TL, Denisov I, Sligar SG, Gupta K, Blair IA, et al. Abstract 2689: Breast cancer inhibition by a novel and potent biguanide, N1-hexyl-N5-benzyl-biguanide Cancer Research. 74: 2689-2689. DOI: 10.1158/1538-7445.Am2014-2689 |
0.394 |
|
| 2013 |
Guo Z, Norris B, Henriksen J, Morgan M, Maher M, Schumacher R, Bliss R, Chu H, Gupta K, Schmechel S, Potter D. Abstract 82: CYP3A4 promotes mammary carcinoma angiogenesis in a cell iIntrinsic fashion. Cancer Research. 73: 82-82. DOI: 10.1158/1538-7445.Am2013-82 |
0.327 |
|
| 2012 |
Guo Z, Mitra R, Luo X, Capdevila J, Lipscomb J, David PA. Abstract 942: CYP3A4 epoxygenase mediates hypoxia-induced biosynthesis of epoxyeicosatrienoic acids (±)-11,12- and (±)-14,15-EET in breast cancer cells Cancer Research. 72: 942-942. DOI: 10.1158/1538-7445.Am2012-942 |
0.352 |
|
| 2011 |
Mitra R, Guo Z, Milani M, Mesaros C, Rodriguez M, Nguyen J, Luo X, Clarke D, Lamba J, Schuetz E, Donner DB, Puli N, Falck JR, Capdevila J, Gupta K, et al. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). The Journal of Biological Chemistry. 286: 17543-59. PMID 21402692 DOI: 10.1074/Jbc.M110.198515 |
0.392 |
|
| 2011 |
Potter DA, Guo Z, Mitra R, Milani M, Rodriguez M, Ding L, Bliss R, Nguyen J, Luo X, Gupta K, Capdevila J, Blair I, Thomas D, Bae YK. Abstract 357: CYP3A4 Activates Stat3 in ER + breast cancer Cancer Research. 71: 357-357. DOI: 10.1158/1538-7445.Am2011-357 |
0.386 |
|
| 2011 |
Guo Z, Mitra R, Milani M, Rodriguez M, Yee D, Sachdev D, Potter DA. Abstract 2288: CYP3A4 monoxygenase regulates IGF-1 signaling in ER-positive breast cancer cells Cancer Research. 71: 2288-2288. DOI: 10.1158/1538-7445.Am2011-2288 |
0.376 |
|
| 2010 |
Milani M, Mitra R, Jha G, Rodriguez M, Guo Z, Weller D, Remmel RP, Potter DA. Abstract 4444: Desthiazolylmethyloxycarbonyl ritonavir is a candidate proteasome activator drug in breast cancer that down-regulates survivin and HER2 Cancer Research. 70: 4444-4444. DOI: 10.1158/1538-7445.Am10-4444 |
0.33 |
|
| 2010 |
Rodriguez M, Mitra R, Guo Z, Becker MA, Yee D, Potter DA. Abstract 4129: Effects of the metabolism of omega-3 fatty acid EPA by CYP1A1 in breast cancer proliferation and survival Cancer Research. 70: 4129-4129. DOI: 10.1158/1538-7445.Am10-4129 |
0.385 |
|
| 2010 |
Guo Z, Mitra R, Potter DA. Abstract 4011: CYP3A4 over-expression promotes ER-positive breast cancer cell growth, in part, through Stat3 activation Cancer Research. 70: 4011-4011. DOI: 10.1158/1538-7445.Am10-4011 |
0.377 |
|
| 2004 |
Wang H, Guo Z, Vath GM, Wagner CR, Hanna PE. Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents. The Protein Journal. 23: 153-66. PMID 15106881 DOI: 10.1023/B:Jopc.0000020082.14480.E2 |
0.574 |
|
| 2004 |
Guo Z, Wagner CR, Hanna PE. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene. Chemical Research in Toxicology. 17: 275-86. PMID 15025497 DOI: 10.1021/Tx030045O |
0.573 |
|
| 2003 |
Guo Z, Vath GM, Wagner CR, Hanna PE. Arylamine N-acetyltransferases: covalent modification and inactivation of hamster NAT1 by bromoacetamido derivatives of aniline and 2-aminofluorene. Journal of Protein Chemistry. 22: 631-42. PMID 14714730 DOI: 10.1023/B:Jopc.0000008728.17159.Dd |
0.549 |
|
| Show low-probability matches. |